JP Stock MarketDetailed Quotes
4886 ASKA Pharmaceutical Holdings
- 1993
- -33-1.63%
20min DelayNot Open Dec 4 15:30 JST
60.91BMarket Cap7.48P/E (Static)
2044High1986Low61.00KVolume2025Open2026Pre Close121.94MTurnover272052wk High0.34%Turnover Ratio30.56MShares171252wk Low210.94EPS TTM36.03BFloat Cap2720Historical High7.48P/E (Static)18.08MShs Float919Historical Low266.51EPS LYR2.86%Amplitude45.00Dividend TTM0.88P/B100Lot Size2.26%Div YieldTTM
ASKA Pharmaceutical Holdings Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | -30.44%2.72B | -19.47%3.92B | 4.86B |
| Net profit before non-cash adjustment | 84.10%9.86B | -13.08%5.36B | --6.16B |
| Total adjustment of non-cash items | -109.41%-288M | 77.71%3.06B | --1.72B |
| -Depreciation and amortization | -14.87%2.66B | 8.39%3.13B | --2.89B |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | --5.95B |
| -Share of associates | 115.79%41M | 205.56%19M | ---18M |
| -Disposal profit | -2,728.81%-3.34B | 98.57%-118M | ---8.27B |
| -Other non-cash items | 920.59%347M | -97.10%34M | --1.17B |
| Changes in working capital | -52.18%-6.85B | -48.97%-4.5B | ---3.02B |
| -Change in receivables | 50.13%-370M | 45.48%-742M | ---1.36B |
| -Change in inventory | -3.27%-2.71B | -282.39%-2.63B | ---687M |
| -Change in payables | 252.45%1.49B | -337.86%-980M | --412M |
| -Provision for loans, leases and other losses | ---- | ---- | ---1.39B |
| -Changes in other current assets | -3,339.22%-5.26B | ---153M | ---- |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | 19.61%-41M | 12.07%-51M | -58M |
| Interest received (cash flow from operating activities) | 22.85%414M | 15.41%337M | 292M |
| Tax refund paid | -89.53%-1.61B | 38.63%-850M | -1.39B |
| Other operating cash inflow (outflow) | 0 | 99.89%-1M | -870M |
| Operating cash flow | -55.66%1.49B | 17.91%3.35B | --2.84B |
| Investing cash flow | |||
| Net PPE purchase and sale | -186.12%-1.32B | -104.74%-461M | --9.73B |
| Net intangibles purchase and sale | 53.33%-133M | 84.15%-285M | ---1.8B |
| Net business purchase and sale | ---1.46B | --0 | ---53M |
| Net investment product transactions | 1,899.05%3.78B | -366.67%-210M | ---45M |
| Net changes in other investments | 596.47%844M | 84.46%-170M | ---1.09B |
| Investing cash flow | 251.51%1.71B | -116.70%-1.13B | --6.74B |
| Financing cash flow | |||
| Net issuance payments of debt | -120.52%-3.14B | 39.40%-1.42B | ---2.35B |
| Net common stock issuance | -83.64%9M | 122.18%55M | ---248M |
| Cash dividends paid | -75.22%-792M | -13.57%-452M | ---398M |
| Net other fund-raising expenses | ---22M | ---- | ---2M |
| Financing cash flow | -116.65%-3.94B | 39.25%-1.82B | ---3B |
| Net cash flow | |||
| Beginning cash position | 2.35%17.51B | 62.67%17.1B | --10.51B |
| Current changes in cash | -285.43%-751M | -93.85%405M | --6.59B |
| Effect of exchange rate changes | -650.00%-15M | ---2M | --0 |
| Cash adjustments other than cash changes | 0.00%-1M | ---1M | ---- |
| End cash Position | -4.38%16.74B | 2.35%17.51B | --17.1B |
| Free cash flow | -98.73%33M | 460.22%2.61B | --465M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data